3 Native American tribes sue opioid industry groups

January 9, 2018

Three Native American tribes in the Dakotas are suing opioid manufacturers and distributors, alleging they concealed and minimized the addiction risk of prescription drugs.

The Rosebud Sioux Tribe, Flandreau Santee Sioux Tribe and the Sisseton Wahpeton Oyate sued 24 industry groups in federal court on Monday. Defendants include drug manufacturers Purdue Pharma, Teva Pharmaceutical Industries and Allergan, and distributors McKesson Corp., Cardinal Health Inc. and AmerisourceBergen Corp.

The lawsuit follows more than 70 cases filed across the country, including in Mississippi, Washington, Massachusetts, Pennsylvania and Ohio. It is one of the first to tie claims to the drugs' impact on Native Americans.

The Cherokee Nation launched a similar suit in April.

The tribes are being represented by former North Dakota U.S. Attorney Tim Purdon and former South Dakota U.S. Attorney Brendan Johnson.

"The prescription opioid crisis has hit Indian Country hard," said Purdon. He added he is "hopeful" that other North Dakota tribes will also file suit.

The complaint noted that the Centers for Disease Control and Prevention found that one in 10 Native Americans used prescription opioids for non-medical purposes in 2012, which is double the rate of whites.

Between 2015 and 2016, Native Americans represented almost 18 percent of opioid-related deaths and 28 percent of patients treated for opioid use in South Dakota. At the time, Native Americans made up 9 percent of the state's population.

"This epidemic has overwhelmed our public-health and law-enforcement services, drained resources for addiction therapy, and sent the cost of caring for children of opioid-addicted parents skyrocketing," said Johnson.

Allegations against the defendants include deceptive marketing, fraudulent and negligent conduct and violations of the Racketeer Influenced and Corrupt Organization Act. The complaint seeks a jury trial to determine monetary damages as well as an "abatement fund" to pay for treatment programs.

The companies hadn't responded to the suit as of Monday.

Explore further: Ohio sues five drugmakers over role in opioid crisis

Related Stories

Ohio sues five drugmakers over role in opioid crisis

May 31, 2017
The US state of Ohio on Wednesday sued five major producers of prescription opioid medications, accusing them of lying about the deadly risks the painkillers—at the center of a nationwide addiction crisis—posed to public ...

Cherokee nation sues retailers, distributors over opioid crisis

April 24, 2017
(HealthDay)—A lawsuit has been filed by an Indian nation against six of the top drug distributors and pharmacies in the United States for harm done by prescription pain medications.

Americans favor treatment, not enforcement, to address opioid crisis

May 23, 2017
Many Americans have been directly touched by the opioid crisis—more than a quarter of Americans and more than a third of millennials, report knowing someone who has been addicted to opioids or prescription painkillers. ...

Washington state, Seattle are latest to sue opioid makers

September 28, 2017
Washington state and the city of Seattle on Thursday joined more than two dozen other government entities across the country suing to hold opioid makers accountable for an addiction crisis that has claimed thousands of lives.

South Carolina sues drug manufacturer over opioid crisis

August 15, 2017
South Carolina has become the latest state to accuse a drug manufacturer of exacerbating its opioid drug crisis by using deceptive marketing, with the state's top prosecutor suing the maker of OxyContin.

States expand investigation of opioid makers, distributors

September 19, 2017
Attorneys general from most states are broadening their investigation into the opioid industry as a nationwide overdose crisis continues to claim thousands of lives.

Recommended for you

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Probiotic use may reduce antibiotic prescriptions, researchers say

September 14, 2018
Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics, say researchers in the U.S., England and the Netherlands.

Recalled blood pressure drugs not linked to increased short term cancer risk

September 12, 2018
Products containing the withdrawn blood pressure drug valsartan are not associated with a markedly increased short term risk of cancer, finds an expedited analysis published by The BMJ today.

Sugar pills relieve pain for chronic pain patients

September 12, 2018
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to ...

A new approach for finding Alzheimer's treatments

September 11, 2018
Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.